Literature DB >> 2784793

Molecular cloning of 114/A10, a cell surface antigen containing highly conserved repeated elements, which is expressed by murine hemopoietic progenitor cells and interleukin-3-dependent cell lines.

G J Dougherty1, R J Kay, R K Humphries.   

Abstract

Monoclonal antibody 114/A10, raised against the murine multipotential hemopoietic progenitor cell line B6SUtA, identifies an antigen highly expressed by primary myeloid progenitor cells, the myelomonocytic leukemia cell line WEHI-3, and various interleukin-3 (IL-3)-dependent cell lines. Western blotting studies indicate that the 114/A10 antigen has a mean relative molecular mass of 150,000 but varies greatly in size range between different cell types. cDNA clones encoding this protein were isolated from a plasmid-based expression vector library prepared from B6SUtA RNA. Three clones corresponding in size to the two major mRNA species detected in IL-3-dependent cell lines (3.0 and 2.2 kilobase pairs) and differing in their utilization of alternative polyadenylation signals were obtained. These clones contain a single long open reading frame of 573 amino acids possessing the typical characteristics of an integral membrane protein. A particularly striking feature of this sequence is the presence at the extracellular amino terminus of a series of eight highly conserved 27-amino acid, serine/threonine-rich (55%) tandem repeats that may serve as sites of extensive glycosylation. The extracellular domain also contains three epidermal growth factor-like cysteine-rich repeats. The distribution and structural characteristics of the 114/A10 antigen suggest a possible regulatory role in the cellular response to IL-3.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2784793

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Generation of ligand-receptor alliances by "SEA" module-mediated cleavage of membrane-associated mucin proteins.

Authors:  Daniel H Wreschner; Michael A McGuckin; Stefanie J Williams; Amos Baruch; Merav Yoeli; Ravit Ziv; Liron Okun; Joseph Zaretsky; Nechama Smorodinsky; Iafa Keydar; Pavlos Neophytou; Martin Stacey; His-Hsien Lin; Siamon Gordon
Journal:  Protein Sci       Date:  2002-03       Impact factor: 6.725

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

Review 3.  An analysis of vertebrate mRNA sequences: intimations of translational control.

Authors:  M Kozak
Journal:  J Cell Biol       Date:  1991-11       Impact factor: 10.539

4.  The SEA module: a new extracellular domain associated with O-glycosylation.

Authors:  P Bork; L Patthy
Journal:  Protein Sci       Date:  1995-07       Impact factor: 6.725

5.  Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44.

Authors:  R K Chiu; A Droll; D L Cooper; S T Dougherty; J F Dirks; G J Dougherty
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

Review 6.  Genetically engineered mucin mouse models for inflammation and cancer.

Authors:  Suhasini Joshi; Sushil Kumar; Sangeeta Bafna; Satyanarayana Rachagani; Kay-Uwe Wagner; Maneesh Jain; Surinder K Batra
Journal:  Cancer Metastasis Rev       Date:  2015-12       Impact factor: 9.264

7.  The Om (1E) mutation in Drosophila ananassae causes compound eye overgrowth due to tom retrotransposon-driven overexpression of a novel gene.

Authors:  N Juni; T Awasaki; K Yoshida; S H Hori
Journal:  Genetics       Date:  1996-07       Impact factor: 4.562

8.  Expression of mucin genes in the human testis and its relationship to spermatogenesis.

Authors:  Ju Tae Seo; Joong Shik Lee; Jin Hyun Jun; Moon Ho Yang
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

9.  Defective development of thymocytes overexpressing the costimulatory molecule, heat-stable antigen.

Authors:  M R Hough; F Takei; R K Humphries; R Kay
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.